ARTICLE
17 February 2017

FDA Revises Control Of Listeria Monocytogenes In Ready-To-Eat Foods

JD
Jones Day
Contributor
Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
The guidance is intended to help industry comply with the requirements of that regulation with respect to measures that can significantly minimize or prevent the contamination of RTE food with Listeria.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

On January 17, 2017, FDA announced the availability of a revised draft guidance for industry titled, "Control of Listeria monocytogenes in Ready-To-Eat Foods." The revised draft guidance is intended for any person who is subject to FDA's "Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Human Food" regulation, and who manufactures, processes, packs, or holds ready-to-eat ("RTE") foods. The guidance is intended to help industry comply with the requirements of that regulation with respect to measures that can significantly minimize or prevent the contamination of RTE food with Listeria. The guidance includes recommendations for controls involving personnel, cleaning and maintenance of equipment, and sanitation, as well as for treatments that kill Listeria and formulations to prevent it from growing during storage of the food between production and consumption. Industry best practices and the "seek and destroy" approach used by the Food Safety and Inspection Service ("FSIS") have also been incorporated into the draft guidance. Comments are due July 26, 2017.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

ARTICLE
17 February 2017

FDA Revises Control Of Listeria Monocytogenes In Ready-To-Eat Foods

United States Food, Drugs, Healthcare, Life Sciences
Contributor
Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More